Q1 2020 Results Slides

Issue link: https://liminalbiosciences.com/resources/i/1247103

Contents of this Issue


Page 5 of 11

© 2020 Liminal BioSciences Inc. Safety our priority Remote working Employee support programs Employees Alström Phase 2 rollover study: Treatment terminated Laboratories: social distancing & safety measure implemented Small Molecules Resubmission of BLA for Ryplazim ® Plasma collection: social distancing & safety measures implemented. Plasma COVID-19 impact on Q1 6

Articles in this issue

view archives of Webcasts - Q1 2020 Results Slides